Seller record · purerawz.co

Pure Rawz

Recorded September 2026 · Standard v1.1

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician, prescriber or medical reviewer is named, and the terms page sends the reader to an outside professional. 3 more criteria also fail; see the table below.

Research vendor. Passes 3 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

An affiliate website covering peptides, SARMs and other research compounds. It states that it does not sell products directly, and each product page routes the reader to third-party sellers while still printing a price range. An FDA warning letter names the storefront.

Operating entity The footer of every page, the contact page, the terms and conditions page and the privacy policy were all read, and none of the four prints a legal entity name.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	FAIL	purerawz.co/terms-conditions
S2	Prescription gating	NOT VERIFIED	purerawz.co/product/bpc-157
S3	Pharmacy identification	FAIL	purerawz.co/about-us
S4	Compounding disclosure	PASS	purerawz.co/product/bpc-157
S5	Analytical documentation	FAIL	purerawz.co
S6	Business address	FAIL	purerawz.co/terms-conditions
S7	Price disclosure	PASS	purerawz.co/product/bpc-157
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician, prescriber or medical reviewer is named, and the terms page sends the reader to an outside professional.Source: purerawz.co/terms-conditions.

S2NOT VERIFIEDAn order path did not resolve, because the cart and the checkout both resolve to the homepage. The check is open.Source: purerawz.co/product/bpc-157.

S3FAILNo pharmacy is named on any captured page, and the about page disclaims all fulfillment and assigns it to third-party websites.Source: purerawz.co/about-us.

S4PASSThe seller offers no compounded drug, and the product page states plainly that the compound is not FDA-approved for human use.Source: purerawz.co/product/bpc-157.

S5FAILThe homepage asserts purity in marketing language, and no certificate, chromatogram or lot report was found on any captured page.Source: purerawz.co.

S6FAILThe contact page prints an email address and a telephone number, and no street address appears in the footer, terms or privacy policy.Source: purerawz.co/terms-conditions.

S7PASSThe BPC-157 page prints a visible price range in dollars with no login and no form in the way.Source: purerawz.co/product/bpc-157.

S8PASSFDA warning letter 715218, September 2025, names the storefront and alleges its tianeptine products are unapproved new drugs; no FDA action has halted the business, and the seller still operates.Source: FDA warning-letter index.

Enforcement documents on file: 1 warning letter

FDA warning letter 715218, issued September 2025, to PureRawzThe tianeptine products offered from purerawz.co are unapproved new drugs intended for human use, despite labeling marketing them for laboratory and research use only.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Sellers passing S1, prescriber requirement

Records dated August 2026

Records dated September 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.